---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-073939"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2022-06-23T23:59:59+00:00"
generated_at: "2026-06-24T23:40:28.651229+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# NextCure shareholders elect three Class III directors and ratify Ernst & Young auditor

## Summary
- Elected David Kabakoff (11,548,824 for, 1,187,004 against), Michael Richman (11,609,302 for, 1,124,238 against), and Stephen W. Webster (11,530,304 for, 1,202,184 against) as Class III directors.
- Ratified Ernst & Young as independent auditor for FY2022 with 17,631,748 for, 53,399 against, 79,774 abstain.
- Broker non-votes on director election totaled 4,783,701, with no broker non-votes on ratification.

## SEC filing metadata
- accession: 0001104659-22-073939
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2022-06-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000110465922073939/0001104659-22-073939-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000110465922073939/tm2219328d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-073939
- JSON: https://secwatch.observer/filing/0001104659-22-073939.json
- Plain text: https://secwatch.observer/filing/0001104659-22-073939.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.